|
Powered by Cell Signaling Technology |
Site Information |
---|
PHMRRsNssGNLHMA SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 449050 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on TLK1: |
References | |
---|---|
Wang W, et al. (2018) Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition. Mol Cell Proteomics
29980616 Curated Info |
|
Kelly R, Davey SK (2013) Tousled-like kinase-dependent phosphorylation of rad9 plays a role in cell cycle progression and g2/m checkpoint exit. PLoS One 8, e85859
24376897 Curated Info |
|
Kodym E, Kodym R, Choy H, Saha D (2008) Sustained metaphase arrest in response to ionizing radiation in a non-small cell lung cancer cell line. Radiat Res 169, 46-58
18159951 Curated Info |
|
Groth A, et al. (2003) Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint. EMBO J 22, 1676-87
12660173 Curated Info |